Alkem Labs Files FY26 Business Responsibility and Sustainability Report

Alkem Laboratories Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026. The report, filed with the BSE, details the company's performance across environmental, social, and governance (ESG) parameters. Key disclosures include corporate identity, business activities focused on pharmaceutical manufacturing (82.4% turnover) and wholesale trade (17.6%), and product sales primarily in pharmaceuticals and nutraceuticals. The company operates 12 plants and 9 offices nationally, serving 28 states and 8 Union Territories, with exports contributing 27.32% of total turnover to over 40 countries. Employee data shows a total of 17,744 employees and 5,642 workers, with specific inclusion metrics for women and differently-abled individuals. The report also notes the transfer of the generic business undertaking to Alkem Wellness Limited effective October 1, 2025.